Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy

Rifaximin (RFX) treatment can attenuate not only hyperammonemia but also Enterococcus faecalis translocation and 10‐7G values, suggesting that RFX treatment may improve intestinal inflammation and result in better overall survival.[Image: see text]

Shranjeno v:
Bibliografske podrobnosti
izdano v:JGH Open
Main Authors: Tamai, Yasuyuki, Iwasa, Motoh, Eguchi, Akiko, Shigefuku, Ryuta, Kamada, Yoshihiro, Miyoshi, Eiji, Takei, Yoshiyuki
Format: Artigo
Jezik:Inglês
Izdano: Wiley Publishing Asia Pty Ltd 2021
Teme:
Brief Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264230/
https://ncbi.nlm.nih.gov/pubmed/34263080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12596
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki